The Association of Racing Commissioners International board of directors April 23 approved a testing threshold level and penalties for the mineral cobalt, a naturally occurring substance in racehorses.
- By Tom LaMarra
United States Trotting Association-funded research into cobalt has resulted in a regulatory testing threshold of 70 parts per billion, the organization said Sept. 30.
A Kentucky racing official Sept. 12 said the state has been at the forefront of research into cobalt, a naturally occurring element said to have blood-doping qualities if used at high levels.
The New York State Gaming Commission Sept. 4 said it will issue a standard 10-year suspension to anyone who violates the harness racing rule prohibiting the use of substances that abnormally oxygenate a horse's blood.
The Association of Racing Commissioners International voted July 31 to approve model rules that create a points system and enhanced penalties for drug violations.
An acting New York State Supreme Court judge has ruled the New York Racing and Wagering Board regulations on out-of-competition testing "require nullification in their entirety."
The Kentucky Horse Racing Commission, operating on a tight schedule, approved a regulation Sept. 7 governing out-of-competition equine drug testing with plans to have it in place in advance of the Nov. 5-6 Breeders' Cup.
- By Tom LaMarra
Anti-Doping Research Inc., which oversees the non-profit Equine Drug Research Institute in California, has developed a test for CERA, a blood-doping agent.
None of the horses that participated in this year's Breeders' Cup World Championships Oct. 24-25 at Santa Anita tested positive for steroids, blood-doping agents or TCO2 (bicarbonate).
The California Horse Racing Board announced Oct. 7 that in conjunction with Breeders' Cup, it will be conducting random out-of-competition testing for horses pre-entered in the World Championships.
By Joe Gorajec - If a drug existed that enhanced performance yet was undetectable by traditional testing methods would it pose a clear and present danger to the integrity of our sport? Would some trainers succumb to the lure of success and easy money knowing they could cheat with impunity? The answers seem obvious.
The Delaware Thoroughbred Racing Commission will issue hefty fines and lengthy suspensions for anyone caught using blood-doping agents effective April 10.
Delaware is taking a harder line on use of erythropoietin and similar blood-doping agents.
Kentucky has performed random testing for blood-doping antibodies in racehorses of all breeds for more than a year, but now it's testing for the actual proteins, a process that could put more teeth in penalties.
A Pennsylvania laboratory is the first to employ a definitive test for erythropoietin--the blood-doping agent commonly known as EPO--and the test resulted in the suspension and fining of a trainer of Standardbreds in Ontario, Canada.
The Kentucky Equine Drug Research Council is devising a sweeping plan for security in barn areas at the state's racetracks, but it appears funding for an increase in manpower could be the major impediment.
Industry officials, during a preliminary meeting Dec. 2 at Philadelphia Park, discussed testing for erythropoietin antibodies that could be implemented in Pennsylvania and perhaps a few other Mid-Atlantic states in 2004.
The racing commissions that govern Thoroughbred and Standardbred racing in Delaware have been testing for erythropoietin antibodies since June 1, and in the future may implement rules to penalize horses that test positive.
New York is poised to become the first state to begin testing horses for blood-doping antibodies used to enhance performance, New York State Racing and Wagering Board officials have announced.
The board of directors of the Association of Racing Commissioners International will consider adoption of a policy that would make treatments such as hypoxic therapy prohibited practices until their impact on horses is scientifically demonstrated.
California has taken the first step to ban the backstretch use of snake venom, which officials believe can be used as a nerve- or joint-numbing agent in sore or injured horses.
Officials said the classification of erythropoeitin -- the blood-doping agent commonly known as EPO -- as a prohibited practice has curbed its use in some jurisdictions but a definitive test for the substance is a must if any regulation is to have teeth.
Antibodies for erythropoeitin, a blood-doping substance commonly known as EPO, were found in six racehorses at Sam Houston Race Park, the Dallas Morning News reported Feb. 18.
The Kentucky Racing Commission has decided to form a committee to explore the testing of horses on days they're not scheduled to race. The decision stems from an earlier classification of erythropoeitin and the process of blood-doping as a prohibited practice.
The Thoroughbred Owners and Breeders Association, quite active on the racehorse medication front for the past few years, is advocating a plan to implement "super tests" for all graded stakes in the United States.
Industry representatives in West Virginia met by teleconference Oct. 15 to devise emergency rules to govern use of adjunct bleeder medications and to ban the practice of blood-doping.
The Pennsylvania State Horse Racing Commission has issued an advisory that erythropoietin, or EPO, and other blood-doping substances and procedures are not permitted in the state.
Most Popular Stories
- Bal a Bali Vying for U.S. Score in American
- Pletcher Considers Preakness Stakes Options
- Princess Violet Tops Ruffian Stakes Entrants
- KHRC Vote on Salix Threshold Triggers Debate
- Unspurned Seeks Repeat Performance in Hendrie
- Beholder, Warren's Veneda Face Off in Vanity
- Wolf Man Rocket Ships in for Peter Pan Stakes
- NYRA to Cap Belmont Attendance at 90,000
- MarketWatch: Jamie Hill on Sires, Pinhooking
- Hardest Core in Man o' War vs. Imagining